Mentor Capital targets to efficiently raise approximately $125 Million from warrant proceeds for operating cancer companies often like those in the Cancer Immunotherapy Index and to invest in those or related leading-edge firms via stock purchase or acquisition.
| Company | Date | Round | Size | Participants |
| AGI Biopharmaceuticals | 11/11 | Venture Round | $4.71M | 1 |
| Hadron Systems | 5/11 | Venture Round | $5M | 1 |
